Medical University of Graz spinout NGFI has licensed additional research conducted by its scientific founders that enables the determination of potassium levels in the human body.

Ascension Ventures led the precision medicine technology provider's series C round, which included Social Capital Partnership and Safeguard Scientifics.

University of Washington medtech spinout Perimatics will develop an anaesthesia monitoring platform that could improve care outcomes.

Sun Pharmaceutical and Lundbeck scored exits in an $89.6m initial public offering by the subcutaneous heart failure therapy developer.

The ocular device spinout hopes to rapidly develop portable devices for eye testing powered by artificial intelligence software.

MyDoc is preparing the ground for its enterprise healthcare platform to launch in Asian markets like Sri Lanka or Hong Kong.

RDD Pharma has secured $9.5m in a series B round that included Pharmascience, and will use the capital to fund clinical trials.

Kinzon Capital has participated in a $17.3m round for medical imaging system developer Deepwise that was led by Danhua Capital.

The spinout is working on a robotic arm for removing gastrointestinal cancer tumours without the need for an operational incision.

The EMBL Ventures-backed immunotherapy developer floated in an underpriced offering and received $20m in a private placement from NEA.